Lutein/Zeaxanthin Isomers and Quercetagetin Combination Safeguards the Retina from Photo-Oxidative Damage by Modulating Neuroplasticity Markers and the Nrf2 Pathway
Özet
Exposure to light-emitting diode (LED) light is a primary cause of retinal damage, resulting in vision loss. Several plant-derived substances, such as lutein and quercetagetin (QCG), show promise in supporting eye health. In this study, the impact of lutein/zeaxanthin (L/Z, Lutemax 2020) and QCG were evaluated individually and together in a rat model of LED-induced retinal damage. A total of 63 Wistar rats were allocated into nine groups (n = 7). For 28 days, the rats received L/Z (10 or 20 mg/kg BW), quercetin (QC, 20 mg/kg BW), QCG (10 or 20 mg/kg BW), or a mixture of different lutein and QCG dosages, after which they were exposed to LED light for 48 h. LED exposure led to a spike in serum malondialdehyde (MDA) and inflammatory cytokines, as well as an increase in retinal NF-κB, ICAM, GFAP, and MCP-1 levels (p < 0.0001 for all). It also reduced serum antioxidant enzyme activities and retinal Nrf2, HO-1, GAP43, NCAM, and outer nuclear layer (ONL) thickness (p < 0.0001 for all). However, administering L/Z and QCG, particularly a 1:1 combination of L/Z and QCG at 20 mg/kg, effectively reversed these changes. The treatment suppressed NF-κB, ICAM, GFAP, and MCP-1 while enhancing Nrf2, HO-1, GAP43, and NCAM and preventing ONL thickness reduction in LED-induced retinal damage rats. In conclusion, while LED light exposure caused retinal damage, treatment with L/Z, QC, and QCG, particularly a combined L/Z and QCG regimen, exhibited protective effects on the retina. This is possibly due to the modulation of neuroplasticity markers and nuclear transcription factors in the rats’ retinal cells.
Anahtar Kelimeler
- Scopus
- 22
- OpenAlex
- 22
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Sahin, Emre | |
| dc.contributor.author | Orhan, Cemal | |
| dc.contributor.author | Sahin, Nurhan | |
| dc.contributor.author | Padigaru, Muralidhara | |
| dc.contributor.author | Morde, Abhijeet | |
| dc.contributor.author | Lal, Mohan | |
| dc.contributor.author | Dhavan, Nanasaheb | |
| dc.contributor.author | Erten, Fusun | |
| dc.contributor.author | Bilgic, Ahmet Alp | |
| dc.contributor.author | Ozercan, Ibrahim Hanifi | |
| dc.contributor.author | Sahin, Kazim | |
| dc.date.accessioned | 2026-10-28T14:54:47.334060694Z | |
| dc.date.available | 2026-10-28T14:54:47.334060694Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Exposure to light-emitting diode (LED) light is a primary cause of retinal damage, resulting in vision loss. Several plant-derived substances, such as lutein and quercetagetin (QCG), show promise in supporting eye health. In this study, the impact of lutein/zeaxanthin (L/Z, Lutemax 2020) and QCG were evaluated individually and together in a rat model of LED-induced retinal damage. A total of 63 Wistar rats were allocated into nine groups (n = 7). For 28 days, the rats received L/Z (10 or 20 mg/kg BW), quercetin (QC, 20 mg/kg BW), QCG (10 or 20 mg/kg BW), or a mixture of different lutein and QCG dosages, after which they were exposed to LED light for 48 h. LED exposure led to a spike in serum malondialdehyde (MDA) and inflammatory cytokines, as well as an increase in retinal NF-κB, ICAM, GFAP, and MCP-1 levels (p < 0.0001 for all). It also reduced serum antioxidant enzyme activities and retinal Nrf2, HO-1, GAP43, NCAM, and outer nuclear layer (ONL) thickness (p < 0.0001 for all). However, administering L/Z and QCG, particularly a 1:1 combination of L/Z and QCG at 20 mg/kg, effectively reversed these changes. The treatment suppressed NF-κB, ICAM, GFAP, and MCP-1 while enhancing Nrf2, HO-1, GAP43, and NCAM and preventing ONL thickness reduction in LED-induced retinal damage rats. In conclusion, while LED light exposure caused retinal damage, treatment with L/Z, QC, and QCG, particularly a combined L/Z and QCG regimen, exhibited protective effects on the retina. This is possibly due to the modulation of neuroplasticity markers and nuclear transcription factors in the rats’ retinal cells. | |
| dc.description.sponsorship | TUBA, (2021-1) | |
| dc.description.sponsorship | OmniActive Health Technologies, (2021-2) | |
| dc.description.sponsorship | OmniActive Health Technologies | |
| dc.description.sponsorship | Türkiye Bilimler Akademisi | |
| dc.identifier.articlenumber | 1543 | |
| dc.identifier.doi | 10.3390/ph16111543 | |
| dc.identifier.eissn | 1424-8247 | |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.issue | 11 | |
| dc.identifier.pmcid | PMC10675275 | |
| dc.identifier.pmid | 38004409 | |
| dc.identifier.scopus | 2-s2.0-85178333788 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/munzur/1979 | |
| dc.identifier.volume | 16 | |
| dc.identifier.wos | WOS:001163426600001 | |
| dc.language.iso | en | |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | |
| dc.relation.ispartof | Pharmaceuticals | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | LED light | |
| dc.subject | NF-κB | |
| dc.subject | Nrf2 | |
| dc.subject | phytochemicals | |
| dc.subject | plasticity markers | |
| dc.subject | retinal damage | |
| dc.subject.other | biological marker | |
| dc.subject.other | caspase 3 | |
| dc.subject.other | catalase | |
| dc.subject.other | flavanoid | |
| dc.subject.other | glutathione peroxidase | |
| dc.subject.other | heme oxygenase 1 | |
| dc.subject.other | intercellular adhesion molecule 1 | |
| dc.subject.other | interleukin 1beta | |
| dc.subject.other | interleukin 6 | |
| dc.subject.other | ketamine | |
| dc.subject.other | malonaldehyde | |
| dc.subject.other | monocyte chemotactic protein 1 | |
| dc.subject.other | nerve cell adhesion molecule | |
| dc.subject.other | neuromodulin | |
| dc.subject.other | protein Bax | |
| dc.subject.other | protein bcl 2 | |
| dc.subject.other | quercetagetin | |
| dc.subject.other | quercetin | |
| dc.subject.other | superoxide dismutase | |
| dc.subject.other | transcription factor | |
| dc.subject.other | transcription factor Nrf2 | |
| dc.subject.other | transcription factor RelA | |
| dc.subject.other | tumor necrosis factor | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | xanthophyll | |
| dc.subject.other | xylazine | |
| dc.subject.other | zeaxanthin | |
| dc.subject.other | animal experiment | |
| dc.subject.other | animal model | |
| dc.subject.other | animal tissue | |
| dc.subject.other | Article | |
| dc.subject.other | edema | |
| dc.subject.other | female | |
| dc.subject.other | histopathology | |
| dc.subject.other | light damage | |
| dc.subject.other | light exposure | |
| dc.subject.other | morphometry | |
| dc.subject.other | nerve cell plasticity | |
| dc.subject.other | nonhuman | |
| dc.subject.other | rat | |
| dc.subject.other | retina | |
| dc.subject.other | retinal ganglion cell layer | |
| dc.subject.other | retinal inner nuclear layer | |
| dc.subject.other | retinal inner plexiform layer | |
| dc.subject.other | retinal nerve fiber layer thickness | |
| dc.subject.other | retinal outer nuclear layer | |
| dc.subject.other | retinal outer plexiform layer | |
| dc.subject.other | signal transduction | |
| dc.subject.other | visual impairment | |
| dc.subject.other | Western blotting | |
| dc.title | Lutein/Zeaxanthin Isomers and Quercetagetin Combination Safeguards the Retina from Photo-Oxidative Damage by Modulating Neuroplasticity Markers and the Nrf2 Pathway | |
| dc.type | Article | |
| rdl.citation.openalex | 22 | |
| rdl.citation.scopus | 22 | |
| rdl.department | Department of Animal Nutrition, Faculty of Veterinary Medicine, Bingol University, Bingol 12000, Turkey | |
| rdl.department | Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig 23119, Turkey | |
| rdl.department | OmniActive Health Technologies Co., Ltd., Mumbai 400013, India | |
| rdl.department | Department of Veterinary Medicine, Pertek Sakine Genc Vocational School, Munzur University, Tunceli 62500, Turkey | |
| rdl.department | Department of Ophtalmology, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, University of Health Sciences, Ankara 06110, Turkey | |
| rdl.department | Department of Pathology, Faculty of Medicine, Firat University, Elazig 23119, Turkey | |
| rdl.oa.status | gold | |
| rdl.oa.status | closed | |
| rdl.oa.status | green | |
| rdl.oa.url | https://www.mdpi.com/1424-8247/16/11/1543/pdf?version=1698824211 | |
| rdl.scopus.quartile | Q1 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED |

